Groundbreaking tech company One Drop has gained US and European approval for its One Drop Chrome service, part of a new offering which could revolutionise how diabetes is managed.<
As the ASCO congress drew to a close, Johnson & Johnson filed for FDA approval of its BCMA-targeting CAR-T therapy Carvykti for use earlier in the treatment pathway fo
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas
